iSpecimen Inc. Files 8-K: Regulation FD Disclosure & Exhibits

Ticker: ISPC · Form: 8-K · Filed: 2025-08-21T00:00:00.000Z

Sentiment: neutral

Topics: 8-K, disclosure, financials

TL;DR

iSpecimen filed an 8-K on 8/21/25 for Reg FD disclosure and exhibits. Details TBD.

AI Summary

On August 21, 2025, iSpecimen Inc. filed a Form 8-K to report a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contain specific financial figures or details of the disclosure at this time.

Why It Matters

This filing indicates that iSpecimen Inc. is making a disclosure under Regulation FD and providing financial statements and exhibits, which could contain material information for investors.

Risk Assessment

Risk Level: low — The filing is a standard procedural update and does not contain specific negative or positive financial news.

Key Players & Entities

FAQ

What specific information is being disclosed under Regulation FD?

The filing does not specify the content of the Regulation FD disclosure, only that it is being made.

What financial statements and exhibits are included in this filing?

The filing indicates that financial statements and exhibits are included, but their specific content is not detailed in the provided text.

When was the earliest event reported in this Form 8-K?

The earliest event reported is August 21, 2025.

What is the principal executive office address for iSpecimen Inc.?

The principal executive office is located at 8 Cabot Road, Suite 1800, Woburn, MA 01801.

What is the SEC file number for iSpecimen Inc.?

The SEC file number for iSpecimen Inc. is 001-40501.

From the Filing

0001213900-25-079167.txt : 20250821 0001213900-25-079167.hdr.sgml : 20250821 20250821080035 ACCESSION NUMBER: 0001213900-25-079167 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20250821 ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250821 DATE AS OF CHANGE: 20250821 FILER: COMPANY DATA: COMPANY CONFORMED NAME: iSpecimen Inc. CENTRAL INDEX KEY: 0001558569 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 270480143 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40501 FILM NUMBER: 251238416 BUSINESS ADDRESS: STREET 1: 8 CABOT ROAD STREET 2: SUITE 1800 CITY: WOBURN STATE: MA ZIP: 08101 BUSINESS PHONE: 781-301-6700 MAIL ADDRESS: STREET 1: 8 CABOT ROAD STREET 2: SUITE 1800 CITY: WOBURN STATE: MA ZIP: 08101 8-K 1 ea0253946-8k_ispecimen.htm CURRENT REPORT false 0001558569 0001558569 2025-08-21 2025-08-21 iso4217:USD xbrli:shares iso4217:USD xbrli:shares     UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   FORM 8-K   CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934   Date of Report (Date of earliest event reported): August 21, 2025   iSpecimen Inc. (Exact name of registrant as specified in its charter)   Delaware   001-40501   27-0480143 (State or other jurisdiction of Incorporation)   (Commission File Number)   (IRS Employer Identification No.)   8 Cabot Road , Suite 1800 Woburn , MA 01801 (Address of principal executive offices, including zip code)   Registrant’s telephone number, including area code: ( 781 ) 301-6700   Not Applicable (Former name or former address, if changed since last report)   Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))   Securities registered pursuant to Section 12(b) of the Act:   Title of each class   Trading symbol(s)   Name of each exchange on which registered Common Stock, par value $0.0001 per share   ISPC   The Nasdaq Stock Market LLC   Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).   Emerging growth company ☒   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐           Item 7.01 Regulation FD Disclosure.   On August 21, 2025, iSpecimen Inc. (the “Company”) issued a press release announcing the successful completion of Milestone 1 in its digital transformation program powered by Salestack Solutions. This achievement marks the installation of the new Salestack platform and provisioning of modern infrastructure. The Company is now positioned to advance to Milestone 2 (Integration), which will focus on connecting all parts of the Company’s business to the Salestack platform to create end-to-end efficiency across operations, custo

View on Read The Filing